Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan
Mirum Pharmaceuticals (MIRM) announced that its partner, Takeda (TAK), has received approval by the Japanese Ministry of Health, Labour, and ...
LIVMARLI Now Approved in Japan for ALGS and PFIC
LIVMARLI is the first and only treatment available for cholestatic pruritus in patients with Alagille syndrome and ...